| Aβ | Amyloid beta |
| AChE | Acetylcholinesterase |
| AGEs | Advanced glycation end products |
| Akt | Protein kinase B |
| APP | Amyloid precursor protein |
| APPsw | Swedish mutation mice, mice carrying the mutant APPK670N, M671L gene |
| ATP | Adenosine-5′-triphosphate |
| Bax | Bcl-2-associated X protein |
| BBB | Blood brain barrier |
| BChE | Butyrylcholinesterase |
| Bcl2 | B-cell lymphoma protein 2 |
| BDNF | Brain-derived neurotrophic factor |
| CAPE | Caffeic acid phenyl ester |
| CBF | Cerebral blood flow |
| CD31 | Platelet/endothelial cell adhesion molecule-1 |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase 2 |
| CSF | Cerebrospinal fluid |
| CYP | Cytochrome P450 |
| DAT | Dopamine transporter |
| ER | Endoplasmic reticulum |
| ERK1/2 | Extracellular signal-regulated kinase-1 and -2 |
| GABA | Gamma-aminobutyric acid |
| GDNF | Glial cell line-derived neurotrophic factor |
| GFAP | Glial fibrillary acidic protein |
| GSK3β | Glycogen synthase kinase 3 beta |
| GSH | Reduced glutathione |
| GSH-Px | Glutathione peroxidase |
| GST | Glutathione-S-transferase |
| HI | Hypoxia-ischemia |
| HIF1α | Hypoxia-inducible factor 1 alpha |
| HO-1 | Heme oxygenase 1 |
| ICAM-1 | Intercellular adhesion molecule 1 |
| IL-1β | Interleukin 1 beta |
| IL-2 | Interleukin 2 |
| IL-4 | Interleukin 4 |
| IL-6 | Interleukin 6 |
| IL-13 | Interleukin 13 |
| i.n. | Intranasal |
| iNOS | Inducible nitric oxide synthase |
| i.p. | Intraperitoneally |
| i.v. | Intravenously |
| LDH | Lactate dehydrogenase |
| 5-LOX | 5-Lipoxygenase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MB | Manganese bisethylenedithiocarbamate |
| MDA | Malondialdehyde |
| mGluR1 | Metabotropic glutamate receptor type 1 |
| mGluR5 | Metabotropic glutamate receptor type 5 |
| MMP-2, -9 | Metallomatrixprotease-2,-9 |
| MPTP | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MRI | Magnetic resonance imaging |
| mTOR | Mammalian target of rapamycin |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NGF | Nerve growth factor |
| NMDA | N-methyl-d-aspartate |
| nNOS | Neuronal nitric oxide synthase |
| NO | Nitric oxide |
| NOS-2 | Nitric oxide synthase-2 |
| NQO-1 | NAD(P)H quinone oxidoreductase |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| 6-OHDA | 6-Hydroxydopamine |
| p53 | Tumor protein p53 |
| p65 | Transcription factor p65 |
| PARP-1 | Poly [ADP-ribose] polymerase 1 |
| p-JNK | C-Jun N-terminal kinases |
| p.o. | Orally |
| PQ | 1,1′-Dimethyl-4,4′-bipyridinium dichloride hydrate |
| RNS | Nitrogen reactive species |
| ROS | Reactive oxygen species |
| rpS3 | Ribosomal protein |
| S100b | S100 calcium-binding protein B |
| SNP | Sodium nitroprusside |
| SOD | Superoxide dismutase |
| SOD2 | Superoxide dismutase 2 |
| TFEB | Transcription factor EB |
| TH+ | Tyrosine hydroxylase immunoreactivity |
| TLR4 | Toll-like receptor 4 |
| TNF-α | Tumor necrosis factor α |
| TrkB | Tirosine kinase receptor |
| UDP | Uridine 5′-diphosphate |
| VCAM-1 | Vascular cell adhesion protein 1 |